Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Polaris Partners is a venture capital firm founded in 1996, headquartered in Boston, with additional offices in New York, San Francisco, and Singapore. The firm has over $5 billion in committed capital across 22 funds, showcasing nearly three decades of investment experience. Polaris has built a strong reputation for its focus on healthcare and life sciences, having backed over 400 companies in these sectors.
The firm operates with a team of 48 professionals, including 30 partners, and has achieved notable milestones such as 35 IPOs and 159 acquisitions. Terry McGuire, one of the founding partners, received the 2024 NVCA Venture Vanguard Award, highlighting the firm's leadership in the venture capital space. Polaris Partners continues to evolve, maintaining a strong presence in North America and Asia, particularly through its 65LAB initiative in Singapore, which facilitates cross-border biotech investments.
Polaris Partners employs three specialized investment strategies: core venture for healthcare and life sciences, a growth fund for profitable B2B SaaS companies, and an innovation fund aimed at commercializing early-stage academic research. The firm typically invests between $10 million and $50 million across various stages, including seed, Series A, Series B, and growth equity. Their healthcare investments focus on innovative care delivery models, digital health, and data science, while the SaaS growth fund targets companies with revenues between $4 million and $20 million.
Polaris has a strong emphasis on partnering with entrepreneurs to build transformational companies, particularly in the healthcare sector. The firm has backed over 400 healthcare companies and brought more than 50 therapies to market, demonstrating its commitment to advancing healthcare solutions. Their investment thesis reflects a deep understanding of the market, aiming to support companies that can deliver significant impact in their respective fields.
Polaris Partners has invested in a diverse portfolio of 412 companies, including notable names such as:
In addition to these exits, Polaris has six unicorns and 35 IPOs in its portfolio. Recent investments include Leyden Labs, which raised $70 million in a Series B round, and Freenome, which is expected to exit in December 2025. The firm has a strong track record of successful exits, with 159 acquisitions to date, underscoring its effectiveness in identifying and nurturing high-potential companies.
Terry McGuire: Founding Partner with extensive experience in venture capital and healthcare investments. He received the 2024 NVCA Venture Vanguard Award.
Jon Flint: Founding Partner known for his leadership in the firm and contributions to the venture capital community.
Amy Schulman: Managing Partner with a strong background in healthcare and life sciences, leading many successful investments.
Brian Chee: Managing Partner who focuses on operational excellence and strategic growth for portfolio companies.
Ellie McGuire: Partner with expertise in healthcare investments and a track record of successful deal sourcing.
Gary Swart: Operating Partner who provides operational support and guidance to portfolio companies.
Dave Barrett: Partner with a focus on technology investments and market strategy.
Amir Nashat: Entrepreneur Partner with a background in building and scaling technology companies.
Alan Crane: Entrepreneur Partner known for his insights into market trends and investment opportunities.
Leah Paquette: Director of Operations and LP Relations, managing relationships with limited partners.
Harold Friedman: Chief Financial Officer overseeing financial operations and fund management.
Shanna Haley: Fund Controller responsible for financial reporting and compliance.
Joanna Zesiger: Director of Finance managing financial strategy and investor relations.
To pitch Polaris Partners, startups should send their pitch deck via email to partnership@polarispartners.com. The deck should include key information about the business model, market opportunity, competitive landscape, and team background. Founders can expect a response within a few weeks, depending on the volume of inquiries.
Polaris prefers warm introductions but is open to direct pitches as well. A clear and concise presentation that highlights the startup's potential for growth and impact will increase the chances of engagement.
The Polaris Innovation Fund is a key initiative aimed at fostering innovation in the healthcare sector. This program partners with entrepreneurs to accelerate the commercial and therapeutic potential of early-stage academic research, providing resources and support to help bring groundbreaking ideas to market.
On December 1, 2025, Polaris Partners made a significant investment in Leyden Labs, participating in a $70 million Series B funding round. This investment highlights the firm's ongoing commitment to supporting innovative healthcare solutions.
Polaris Partners also anticipates an exit for Freenome in December 2025, further demonstrating its active engagement in the investment landscape. The firm continues to maintain a strong portfolio with over 400 companies and a history of successful exits, including 35 IPOs and 159 acquisitions.
What are Polaris Partners' investment criteria?
Polaris Partners focuses on healthcare and life sciences, as well as profitable B2B SaaS companies. They typically invest between $10 million and $50 million across seed, Series A, Series B, and growth equity stages.
How can startups apply or pitch to Polaris Partners?
Startups can reach out to Polaris Partners via email at partnership@polarispartners.com. A well-prepared pitch deck should include details about the business model, market opportunity, and team background.
What differentiates Polaris Partners from other venture firms?
Polaris Partners has a unique focus on healthcare and life sciences, with nearly 30 years of experience and a proven track record of over 400 backed companies and 50 therapies brought to market. Their growth fund specifically supports profitable SaaS founders seeking capital while retaining significant ownership.
What is the geographic scope of Polaris Partners' investments?
Polaris primarily invests in North America and Asia, with a notable presence in Singapore through their 65LAB initiative, which facilitates cross-border biotech investments.
What is Polaris Partners' post-investment involvement like?
Polaris Partners actively supports its portfolio companies through mentorship, operational support, and strategic guidance, leveraging their extensive network and industry expertise to help founders succeed.
What is the typical check size for investments made by Polaris Partners?
Polaris Partners typically invests between $10 million and $50 million, with a sweet spot around $20 million for their investments.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.